Scott Gottlieb, Director at Molecular Insight Pharmaceuticals, Inc. (MIPI), bought 4,000 shares at $3.83 ($15K) on 2009-05-29, disclosed to the SEC on 2009-06-01.
Open-market purchase of $15k MIPI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| TEM | SELL | 2025-04-03 | $2.4M | — | Filing → |
| TEM | SELL | 2025-03-19 | $2.7M | — | Filing → |
| PFE | BUY | 2024-10-31 | $28K | — | Filing → |